Literature DB >> 633577

Effect of vidarabine on chronic hepatitis B virus infection.

R B Pollard, J L Smith, A Neal, P B Gregory, T C Merigan, W S Robinson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 633577

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  21 in total

1.  Randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection.

Authors:  I V Weller; A S Lok; A Mindel; P Karayiannis; S Galpin; J Monjardino; S Sherlock; H C Thomas
Journal:  Gut       Date:  1985-07       Impact factor: 23.059

2.  Inhibition of hepatitis B virus deoxyribonucleic acid polymerase by the 5'-triphosphates of 9-beta-D-arabinofuranosyladenine and 1-beta-D-arabinofuranosylcytosine.

Authors:  G Hess; W Arnold; K H Meyer zum Büschenfelde
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

Review 3.  Historical treatment of chronic hepatitis B and chronic hepatitis C.

Authors:  P Ferenci
Journal:  Gut       Date:  1993       Impact factor: 23.059

4.  Inhibition of salvage pathway enzymes by adenine arabinoside 5'-monophosphate (ara-AMP).

Authors:  H J Becher; P Schollmeyer
Journal:  Klin Wochenschr       Date:  1983-08-01

Review 5.  Interferons and interferon inducers: development of clinical usefulness and therapeutic promise.

Authors:  R B Pollard
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

6.  Effects of interferon and adenine arabinoside treatment of hepatitis B virus infection on cellular immune responses.

Authors:  B Hafkin; R B Pollard; M L Tiku; W S Robinson; T C Merigan
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

7.  Preliminary trial of recombinant fibroblast interferon in chronic hepatitis B virus infection.

Authors:  M Eisenberg; S Rosno; G Garcia; M W Konrad; P B Gregory; W S Robinson; T C Merigan
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

8.  Potent inhibition of hepatitis B virus production in vitro by modified pyrimidine nucleosides.

Authors:  E Matthes; P Langen; M von Janta-Lipinski; H Will; H C Schröder; H Merz; B E Weiler; W E Müller
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191

9.  Comparison of properties of woodchuck hepatitis virus and human hepatitis B virus endogenous DNA polymerases.

Authors:  O Hantz; T Ooka; L Vitvitski; C Pichoud; C Trepo
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

10.  Effects of adenine arabinoside on cellular immune responses in patients with chronic hepatitis B.

Authors:  I Hyodo; G Yamada; K Manabe; H Okushin; M Mizuno; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1986-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.